Abstract:Intratumoral hypoxia significantly constrains the susceptibility of solid tumors to oxygen-dependent photodynamic therapy (PDT), and effort to reverse such hypoxia has achieved limited success to date. Herein, we developed a novel engineered bacterial system capable of targeting hypoxic tumor tissues and efficiently mediating the photodynamic treatment of these tumors. For this system, we genetically engineered Escherichia coli to express catalase, after which we explored an electrostatic adsorption approach to link black phosphorus quantum dots (BPQDs) to the surface of these bacteria, thereby generating an engineered E. coli/BPQDs (EB) system. Following intravenous injection, EB was able to target hypoxic tumor tissues. Subsequent 660 nm laser irradiation drove EB to generate reactive oxygen species (ROS) and destroy the membranes of these bacteria, leading to the release of catalase that subsequently degrades hydrogen peroxide to yield oxygen. Increased oxygen levels alleviate intratumoral hypoxia, thereby enhancing BPQD-mediated photodynamic therapy. This system was able to efficiently kill tumor cells in vivo, exhibiting good therapeutic efficacy. In summary, this study is the first to report the utilization of engineered bacteria to facilitate PDT, and our results highlight new avenues for BPQD-mediated cancer treatment.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.0c20254?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.0c20254</a>.Materials, methods, oxygen generation in 3% H2O2 solution after different bacteria lysis treatments as measured by a dissolved oxygen meter (Figure S1); AFM image of BPQDs (Figure S2); absorbance spectra of EB before and after rotation (Figure S3); height profiles of the BPQDs (Figure S4); CLSM photo of pure E. coli modified with DSPE-PEG-Cy5 (Figure S5); DCFH-DA fluorescence intensity (Figure S6); viability of E. coli survival rate (Figure S7); blood biochemistry data of kidney function markers: CRE and BUN (Figures S8 and S9); blood biochemistry data of liver function markers: ALT, ALP, and AST (Figure S10); histopathologic examination of tissues (Figure S11); and DCFH-DA fluorescence intensity (Figure S12) (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c20254/suppl_file/am0c20254_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

A Strategy for Enhanced Tumor Targeting of Photodynamic Therapy Based on Escherichia Coli-Driven Drug Delivery System

Genetically modified bacteria for targeted phototherapy of tumor

A Tumor-Targeted Ganetespib-zinc Phthalocyanine Conjugate for Synergistic Chemo-Photodynamic Therapy.

Aggregation-Induced Emission Photosensitizer/Bacteria Biohybrids Enhance Cerenkov Radiation-Induced Photodynamic Therapy by Activating Anti-Tumor Immunity for Synergistic Tumor Treatment

Genetically engineered probiotics for an optical imaging-guided tumor photothermal therapy/immunotherapy

Sequential delivery of photosensitizers and checkpoint inhibitors by engineered bacteria for enhanced cancer photodynamic immunotherapy

Optically-controlled bacterial metabolite for cancer therapy

A Tumor Environment‐Activated Photosensitized Biomimetic Nanoplatform for Precise Photodynamic Immunotherapy of Colon Cancer

A Microrobotic System Based on Engineered Bacteria for Targeted Self‐Driven Photodynamic Therapy

Chemically Enhanced Live Probiotic for in Vivo Tumor Targeting and Inhibition

Novel Engineered Bacterium/Black Phosphorus Quantum Dot Hybrid System for Hypoxic Tumor Targeting and Efficient Photodynamic Therapy

Photothermal Lysis of Engineered Bacteria to Modulate Amino Acid Metabolism against Tumors

Erythrocyte Membrane Bioengineered Nanoprobes Via Indocyanine Green-Directed Assembly for Single NIR Laser-Induced Efficient Photodynamic/photothermal Theranostics.

Light-triggered photosynthetic engineered bacteria for enhanced-photodynamic therapy by relieving tumor hypoxic microenvironment

A Single Molecule Drug Targeting Photosensitizer for Enhanced Breast Cancer Photothermal Therapy

Enhancing photothermal therapy of tumors with image-guided thermal control of gene-expressing bacteria

Zinc-Phthalocyanine-Loaded Extracellular Vesicles Increase Efficacy and Selectivity of Photodynamic Therapy in Co-Culture and Preclinical Models of Colon Cancer

In Vitro and in Vivo Evaluation of Improved EGFR Targeting Peptide-Conjugated Phthalocyanine Photosensitizers for Tumor Photodynamic Therapy

Nanocoated bacteria with H2S generation-triggered self-amplified photothermal and photodynamic effect for breast cancer therapy

Photodynamic Therapy-Improved Oncolytic Bacterial Immunotherapy with FAP-encoding S. Typhimurium.

Bacteria‐Assisted Selective Photothermal Therapy for Precise Tumor Inhibition